134 related articles for article (PubMed ID: 8521916)
1. The non-competitive AMPA/kainate receptor antagonist, GYKI 52466, potentiates the anticonvulsant activity of conventional antiepileptics.
Borowicz KK; Gasior M; Kleinrok Z; Czuczwar SJ
Eur J Pharmacol; 1995 Aug; 281(3):319-26. PubMed ID: 8521916
[TBL] [Abstract][Full Text] [Related]
2. Non-N-methyl-D-aspartate receptor antagonism by 3-N-substituted 2,3-benzodiazepines: relationship to anticonvulsant activity.
Donevan SD; Yamaguchi S; Rogawski MA
J Pharmacol Exp Ther; 1994 Oct; 271(1):25-9. PubMed ID: 7525924
[TBL] [Abstract][Full Text] [Related]
3. LY 300164, a novel antagonist of AMPA/kainate receptors, potentiates the anticonvulsive activity of antiepileptic drugs.
Czuczwar SJ; Swiader M; Kuźniar H; Gasior M; Kleinrok Z
Eur J Pharmacol; 1998 Oct; 359(2-3):103-9. PubMed ID: 9832379
[TBL] [Abstract][Full Text] [Related]
4. Competitive NMDA-receptor antagonists, LY 235959 and LY 233053, enhance the protective efficacy of various antiepileptic drugs against maximal electroshock-induced seizures in mice.
Borowicz KK; Gasior M; Kleinrok Z; Czuczwar SJ
Epilepsia; 1996 Jul; 37(7):618-24. PubMed ID: 8681893
[TBL] [Abstract][Full Text] [Related]
5. Interaction of GYKI 52466, a selective non-competitive antagonist of AMPA/kainate receptors, with conventional antiepileptic drugs in amygdala-kindled seizures in rats.
Borowicz KK; Duda AM; Kleinrok Z; Czuczwar SJ
Pol J Pharmacol; 2001; 53(2):101-8. PubMed ID: 11787948
[TBL] [Abstract][Full Text] [Related]
6. Influence of antazoline and ketotifen on the anticonvulsant activity of conventional antiepileptics against maximal electroshock in mice.
Swiader M; Wielosz M; Czuczwar SJ
Eur Neuropsychopharmacol; 2004 Aug; 14(4):307-18. PubMed ID: 15163441
[TBL] [Abstract][Full Text] [Related]
7. Influence of aminophylline and strychnine on the protective activity of excitatory amino acid antagonists against maximal electroshock-induced convulsions in mice.
Tutka P; Turski WA; Kleinrok Z; Czuczwar SJ
J Neural Transm (Vienna); 1996; 103(3):307-14. PubMed ID: 8739842
[TBL] [Abstract][Full Text] [Related]
8. GYKI 52466 [1-(4-aminophenyl)-4-methoxy-7,8-methylenedioxy-5H-2,3-benzodiazepine hydrochloride] and the anticonvulsive activity of conventional antiepileptics against pentetrazol in mice.
Czuczwar SJ; Gasior M; Kamiński R; Kleinrok Z; Kozicka M; Ossowska G; Pietrasiewicz T
Mol Chem Neuropathol; 1998 Apr; 33(3):149-62. PubMed ID: 9642669
[TBL] [Abstract][Full Text] [Related]
9. Influence of MK-801 on the anticonvulsant activity of antiepileptics.
Urbańska E; Dziki M; Kleinrok Z; Czuczwar SJ; Turski WA
Eur J Pharmacol; 1991 Aug; 200(2-3):277-82. PubMed ID: 1782990
[TBL] [Abstract][Full Text] [Related]
10. Effect of 5-fluoroindole-2-carboxylic acid (an antagonist of the NMDA receptor-associated glycine site) on the anticonvulsive activity of conventional antiepileptic drugs.
Kamiński R; Przywara B; Gasior M; Kleinrok Z; Czuczwar SJ
J Neural Transm (Vienna); 1998; 105(2-3):133-46. PubMed ID: 9660092
[TBL] [Abstract][Full Text] [Related]
11. The competitive NMDA antagonist, D-CPP-ene, potentiates the anticonvulsant activity of conventional antiepileptics against maximal electroshock-induced seizures in mice.
Zarnowski T; Kleinrok Z; Turski WA; Czuczwar SJ
Neuropharmacology; 1994 May; 33(5):619-24. PubMed ID: 7936096
[TBL] [Abstract][Full Text] [Related]
12. The influence of L-NG-nitroarginine methyl ester, an inhibitor of nitric oxide synthase, upon the anticonvulsive activity of conventional antiepileptic drugs against maximal electroshock in mice.
Borowicz KK; Starownik R; Kleinrok Z; Czuczwar SJ
J Neural Transm (Vienna); 1998; 105(1):1-12. PubMed ID: 9588756
[TBL] [Abstract][Full Text] [Related]
13. 2-phosphonomethyl-pentanedioic acid (glutamate carboxypeptidase II inhibitor) increases threshold for electroconvulsions and enhances the antiseizure action of valproate against maximal electroshock-induced seizures in mice.
Luszczki JJ; Mohamed M; Czuczwar SJ
Eur J Pharmacol; 2006 Feb; 531(1-3):66-73. PubMed ID: 16403497
[TBL] [Abstract][Full Text] [Related]
14. Influence of combined treatment with NMDA and non-NMDA receptor antagonists on electroconvulsions in mice.
Czuczwar SJ; Borowicz KK; Kleinrok Z; Tutka P; Zarnowski T; Turski WA
Eur J Pharmacol; 1995 Aug; 281(3):327-33. PubMed ID: 8521917
[TBL] [Abstract][Full Text] [Related]
15. Effects of the non-NMDA antagonists NBQX and the 2,3-benzodiazepine GYKI 52466 on different seizure types in mice: comparison with diazepam and interactions with flumazenil.
Löscher W; Hönack D
Br J Pharmacol; 1994 Dec; 113(4):1349-57. PubMed ID: 7889291
[TBL] [Abstract][Full Text] [Related]
16. Influence of D(-)CPP and (+/-)CPP upon the protective action of conventional antiepileptic drugs against electroconvulsions in mice.
Borowicz KK; Kleinrok Z; Czuczwar SJ
Pol J Pharmacol; 2000; 52(6):431-9. PubMed ID: 11558463
[TBL] [Abstract][Full Text] [Related]
17. Interaction of famotidine, an H2 histamine receptor antagonist, with conventional antiepileptic drugs in mice.
Świąder MJ; Czuczwar SJ
Pharmacol Rep; 2014 Jun; 66(3):485-91. PubMed ID: 24905528
[TBL] [Abstract][Full Text] [Related]
18. Anticonvulsant activity of AMPA/kainate antagonists: comparison of GYKI 52466 and NBOX in maximal electroshock and chemoconvulsant seizure models.
Yamaguchi S; Donevan SD; Rogawski MA
Epilepsy Res; 1993 Jul; 15(3):179-84. PubMed ID: 7693450
[TBL] [Abstract][Full Text] [Related]
19. Rimcazole, a sigma receptor ligand, and the anticonvulsive action of conventional antiepileptic drugs.
Borowicz KK; Wilczyński PM; Kleinrok Z; Czuczwar SJ
J Neural Transm (Vienna); 1998; 105(6-7):601-12. PubMed ID: 9826105
[TBL] [Abstract][Full Text] [Related]
20. Competitive NMDA receptor antagonists enhance the antielectroshock activity of various antiepileptics.
Pietrasiewicz T; Czechowska G; Dziki M; Turski WA; Kleinrok Z; Czuczwar SJ
Eur J Pharmacol; 1993 Nov; 250(1):1-7. PubMed ID: 7907019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
